![](https://www.mitacs.ca/wp-content/uploads/2023/12/generic-logo-background.png)
Bladder cancer is the fifth most common form of cancer in Canada, however progress in the development of safer and more effective therapies has been slow. The use of antibody drug conjugates (ADC) is a promising therapeutic option that would allow for targeted killing of cancer cells, if the obstacle of getting the drug inside […]
Read More